Get the Stockscreener App
18.19
0.22%
0.04
Pre-market:
18.14
-0.05
-0.27%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $18.19, with a volume of 40.71M.
It is up +0.22% in the last 24 hours and up +1.00% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
See More
Previous Close:
$18.15
Open:
$18.2
24h Volume:
40.71M
Relative Volume:
0.94
Market Cap:
$34.87B
Revenue:
$15.12B
Net Income/Loss:
$1.47B
P/E Ratio:
23.81
EPS:
0.764
Net Cash Flow:
$1.72B
1W Performance:
-3.09%
1M Performance:
+1.00%
6M Performance:
-11.44%
1Y Performance:
-22.33%
1-Day Range:
$17.99
$18.30
1-Week Range:
$17.99
$19.18
52-Week Range:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, EL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
18.19 | 34.79B | 15.12B | 1.47B | 1.72B | 0.764 |
|
PG
Procter Gamble Co
|
158.30 | 371.19B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
69.07 | 151.09B | 56.67B | 6.96B | 7.39B | 3.1175 |
|
CL
Colgate Palmolive Co
|
95.28 | 76.56B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
EL
Estee Lauder Cos Inc
|
99.21 | 35.71B | 14.67B | -178.00M | 1.14B | -0.5002 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue (NYSE: KVUE) grants CTO 79,407 RSUs vesting 2027-2029 - Stock Titan
Kenvue (NYSE: KVUE) grants 63,525 RSUs to Chief Scientific Officer - Stock Titan
Starboard Value Takes Stake in Fluor as Industrial Investment Cycles Reaccelerate - The Motley Fool
Kenvue (KVUE) Valuation Revisited After Schafer Cullen Exit And Ongoing Consumer Headwinds - simplywall.st
US Bancorp DE Has $2.41 Million Stock Position in Kenvue Inc. $KVUE - MarketBeat
Skba Capital Management LLC Has $13.73 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Elo Mutual Pension Insurance Co Has $4.44 Million Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Tuesday, underperforms market - MarketWatch
Kenvue Inc (KVUE) Trading Down 3.2% on Mar 3 - GuruFocus
Zyrtec® joins PGA TOUR as the first official allergy relief sponsor - Kenvue
Kenvue Inc. $KVUE Shares Sold by Bahl & Gaynor Inc. - MarketBeat
APG Asset Management N.V. Has $18.23 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue Shares Tumble 27.9% Below 52-Week High as Earnings Misses and Strategic Uncertainty Send Stock to 229th in Daily Trading Activity - Bitget
Will Strong Q4 Results and Schafer Cullen’s Exit Change Kenvue’s (KVUE) Investment Narrative? - simplywall.st
Kimberly-Clark Seeks Clearance To Acquire Kenvue - supermarketnews.co.nz
Kimberly-Clark seeks New Zealand clearance for Kenvue acquisition - MLex
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
Neutrogena agrees to $4.7M class action settlement over Skin360 biometric data - Class Action Lawsuits
Here’s Why SCCM Enhanced Equity Portfolio Exited Its Position in Kenvue (KVUE) - Insider Monkey
TD Asset Management Inc Sells 1,931,369 Shares of Kenvue Inc. $KVUE - MarketBeat
KVUE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Discipline and Rules-Based Execution in KVUE Response - Stock Traders Daily
Kenvue Inc. (KVUE): A Bull Case Theory - Finviz
Mitsubishi UFJ Asset Management Co. Ltd. Has $71.93 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
American Century Companies Inc. Raises Stock Position in Kenvue Inc. $KVUE - MarketBeat
Westpac Banking Corp Sells 192,981 Shares of Kenvue Inc. $KVUE - MarketBeat
Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol safety - WHTC
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
Tylenol maker announces layoffs ahead of Kimberly-Clark buyout - The Business Journals
Kenvue Bid to Dismiss Texas AG Lawsuit Rejected by Judge - marketscreener.com
Kenvue Bid to Dismiss Texas AG Lawsuit Rejected by Judge, Reuters Reports - marketscreener.com
Kenvue effort to dismiss Tylenol case rejected by Texas judge (KVUE:NYSE) - Seeking Alpha
Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol's safety - Yahoo
Judge rejects Kenvue bid to dismiss Texas Attorney General's lawsuit over marketing of Tylenol, court order shows - marketscreener.com
U.S. District Court for the District of New Jersey Judge Trims Benzene Class Claims Against Johnson & Johnson Consumer Inc. and Kenvue Inc. - USA Herald
NJ Judge Trims J&J and Neutrogena Benzene Suit - Law360
Kenvue Inc. stock falls Wednesday, underperforms market - MarketWatch
Kimberly-Clark Kenvue Deal Reshapes Growth Story And Investor Trade Offs - Yahoo Finance
Kenvue Agrees To $4.7 Million Skin360 Settlement - Happi | Household And Personal Products Industry
Assessing Kenvue (KVUE) Valuation As Recent Share Price Momentum Meets Mixed Longer Term Returns - simplywall.st
RBC Capital Reaffirms Their Hold Rating on Kenvue, Inc. (KVUE) - The Globe and Mail
Kenvue, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Metrics - Markets Mojo
Kimberly-Clark Details “Powering Care” Plan, Kenvue Integration Ahead of 2026 Close - MarketBeat
Jefferies Adjusts Price Target on Kenvue to $19 From $18, Maintains Hold Rating - marketscreener.com
Kenvue (KVUE) stock ticks up premarket as Kimberly-Clark deal gap and cost cuts stay in focus - Bez Kabli
Kenvue Announces Job Cuts - Beauty Packaging
Kenvue Inc. (NYSE:KVUE) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Is Kenvue’s Earnings Beat And CFO Exit Altering The Investment Case For Kenvue (KVUE)? - simplywall.st
Weekly Recap: Kenvue’s Job Cuts, Tide’s Fiber Tile & Method’s Dish Soap - Happi | Household And Personal Products Industry
Post‑Merger Risk Warning: Why Kenvue Holders in K‑C Stock May Face Integration, Leverage, and Valuation Pressures - The Globe and Mail
Assetmark Inc. Lowers Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):